Suppr超能文献

耐药结核病的分子诊断;文献综述

Molecular Diagnosis of Drug-Resistant Tuberculosis; A Literature Review.

作者信息

Nguyen Thi Ngoc Anh, Anton-Le Berre Véronique, Bañuls Anne-Laure, Nguyen Thi Van Anh

机构信息

UMR MIVEGEC, Institute of Research for Development, Centre National de la Recherche Scientifique, University of Montpellier, Montpellier, France.

Laboratory of Tuberculosis, Department of Bacteriology, National Institute of Hygiene and Epidemiology, Hanoi, Vietnam.

出版信息

Front Microbiol. 2019 Apr 16;10:794. doi: 10.3389/fmicb.2019.00794. eCollection 2019.

Abstract

Drug-resistant tuberculosis is a global health problem that hinders the progress of tuberculosis eradication programs. Accurate and early detection of drug-resistant tuberculosis is essential for effective patient care, for preventing tuberculosis spread, and for limiting the development of drug-resistant strains. Culture-based drug susceptibility tests are the gold standard method for the detection of drug-resistant tuberculosis, but they are time-consuming and technically challenging, especially in low- and middle-income countries. Nowadays, different nucleic acid-based assays that detect gene mutations associated with resistance to drugs used to treat tuberculosis are available. These tests vary in type and number of targets and in sensitivity and specificity. In this review, we will describe the available molecular tests for drug-resistant tuberculosis detection and discuss their advantages and limitations.

摘要

耐多药结核病是一个全球性的健康问题,阻碍了结核病根除计划的进展。准确、早期检测耐多药结核病对于有效的患者护理、预防结核病传播以及限制耐药菌株的产生至关重要。基于培养的药敏试验是检测耐多药结核病的金标准方法,但它们耗时且技术要求高,尤其是在低收入和中等收入国家。如今,有不同的基于核酸的检测方法可用于检测与用于治疗结核病的药物耐药性相关的基因突变。这些检测在靶点的类型和数量以及灵敏度和特异性方面各不相同。在本综述中,我们将描述现有的用于检测耐多药结核病的分子检测方法,并讨论它们的优点和局限性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e59a/6477542/05d0e24a2dc6/fmicb-10-00794-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验